首页 | 本学科首页   官方微博 | 高级检索  
检索        

加贝酯在ERCP诊治术后的临床应用评价
引用本文:何亚龙,张尤历.加贝酯在ERCP诊治术后的临床应用评价[J].临床消化病杂志,2006,18(3):161-162.
作者姓名:何亚龙  张尤历
作者单位:江苏大学附属医院消化内科,镇江,212001
摘    要:目的观察加贝酯在预防ERCP术后引起的高淀粉酶血症和急性胰腺炎的有效性。方法两组行ERCP的病人,试验组应用加贝酯。观察试验组和对照组患者术后血清淀粉酶的变化。结果试验组术后高淀粉酶血症及急性胰腺炎发生率明显低于对照组(P<0.05)。结论加贝酯能有效预防ERCP术后高淀粉酶血症及急性胰腺炎的发生。

关 键 词:加贝酯  内镜下逆行胰胆造影术
文章编号:1005-541X(2006)03-161-02
收稿时间:2005-11-30
修稿时间:2005年11月30

The Effects of Gabexate Mesilate in Post-ERCP Patients
HE YA-long,ZHANG You-li.The Effects of Gabexate Mesilate in Post-ERCP Patients[J].Chinese Journal of Clinical Gastroenterology,2006,18(3):161-162.
Authors:HE YA-long  ZHANG You-li
Institution:Department of Gastroenterology, Affilated Hospital, Jiangsu University, Zhenjiang 212001, Chian
Abstract:Objective To investigate the effects of gabexate mesilate on avoiding the hyperamylasemia and the acute pancreatitis. Methods Two groups of endoscopic retrograde cholangiopancreatrography(ERCP)were investigated, the trials were given gabexate mesilate. And then, observe the level of the serum amylase and the incidence of the acute pancreatitis. Results The level of the serum amylase and the incidence of the acute pancreatitis in the trials were lower than that in the controls(P<0.05).Conclusion The result suggest that gabexate mesilate may possibly prevent post-ERCP pancreatitis and hyperamylasemia.
Keywords:Gabexate mesilate  Endoscopic restrograde cholangiopancreatrography(ERCP)
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号